Drug General Information
Drug ID	D0JI8S
Former ID	DNC004903
Drug Name	3,4-difluorobenzaldehyde O-benzoyloxime
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[528384]
Structure		Download 2D MOL 3D MOL
Formula	C14H9F2NO2
Canonical SMILES	C1=CC=C(C=C1)C(=O)ON=CC2=CC(=C(C=C2)F)F
InChI	1S/C14H9F2NO2/c15-12-7-6-10(8-13(12)16)9-17-19-14(18)11-4-2-1-3-5-11/h1-9H/b17-9+
InChIKey	HOHACQRGFZUDCD-RQZCQDPDSA-N
PubChem Compound ID	11470979
Target and Pathway
Target(s)	Lipoprotein-associated phospholipase A2	Target Info	Inhibitor	[528384]
KEGG Pathway	Ether lipid metabolism
	Metabolic pathways
	Biosynthesis of antibiotics
Pathway Interaction Database	Lissencephaly gene (LIS1) in neuronal migration and development
WikiPathways	IL1 and megakaryotyces in obesity
	Synthesis, Secretion, and Deacylation of Ghrelin
References
Ref 528384	Bioorg Med Chem Lett. 2006 Nov 1;16(21):5576-9. Epub 2006 Aug 21.Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde O-heterocycle-4-carbonyloxime.
Ref 528384	Bioorg Med Chem Lett. 2006 Nov 1;16(21):5576-9. Epub 2006 Aug 21.Potent inhibitors of lipoprotein-associated phospholipase A(2): benzaldehyde O-heterocycle-4-carbonyloxime.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.